v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities    
Net loss $ (1,441,260) $ (764,655)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities    
Amortization of intangible assets 49,500 49,636
Write-down of intangible assets 99,949 0
Common stock issued for services 11,760 0
Amortization of debt discount on Series B and D Preferred Stock 46,800 0
(Gain) loss on change in fair value of derivative liability (40,258) 111,523
Changes in Operating Assets and Liabilities    
Decrease in accounts receivable 0 5,460
Decrease in prepaid expenses and other current assets 2,139 166
(Decrease) Increase in accounts payable (125,679) 118,276
Increase in accrued liabilities 816,103 159,776
Increase in derivative liability 233,003 111,612
(Decrease) increase in shares payable to related parties (18,638) 3,413
Increase in salaries payable to related parties 171,530 158,402
Net Cash Used in Operating Activities (195,051) (46,391)
Cash Flows Used in Investing Activities    
Net Cash Used in Investing Activities 0 0
Cash Flows from Financing Activities    
Cash received from sale of Series B Preferred Stock 75,600
Cash received from sale of Series D Preferred Stock 210,000
Cash paid for offering costs (12,200) (6,260)
Net Cash Provided by Financing Activities 197,800 69,340
Net Increase in Cash and Cash Equivalents 2,749 22,949
Cash and Cash Equivalents - Beginning of Period 23,593 644
Cash and Cash Equivalents - End of Period 26,342 23,593
Supplement Disclosures of Cash Flow Information    
Interest paid 0 0
Income taxes paid 0 0
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Conversion of convertible notes payable and derivative liabilities 0 115,825
Common stock issued in settlement of accounts payable 9,985 0
Issuance of Series E Preferred stock in settlement of compensation payable $ 1,448,861 $ 0